Form 4: LeMaitre Vascular CFO Reports Stock Transactions Following Vesting of Restricted Stock Units

LeMaitre Vascular's Chief Financial Officer, Joseph P. Pellegrino Jr., reported transactions involving common stock and dividend equivalent rights following the vesting of restricted stock units.

Summary

• Joseph P. Pellegrino Jr., the Chief Financial Officer of LeMaitre Vascular, Inc., reported several transactions on December 2, 2024.
• These transactions include the acquisition of 12 shares of common stock through the release of dividend equivalent rights.
• Additionally, 158 shares were disposed of to cover tax withholding obligations related to the vesting of restricted stock units.
• Following these transactions, Mr. Pellegrino directly owns 8,663 shares of common stock.
• The dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 2, 2020.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing detailing insider transactions, which is neither positive nor negative in itself.

Industry Context

This is a routine filing related to insider transactions, which is common for publicly traded companies. It reflects the vesting of equity compensation for a key executive.

Comparison to Industry Standards

• Form 4 filings are standard practice for publicly traded companies in the US, and this filing is consistent with those requirements.
• The transactions are typical for executives receiving stock-based compensation, with shares often withheld to cover tax obligations.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect routine executive compensation.

Key Dates

Keywords

Form 4, insider trading, stock transaction, restricted stock units, dividend equivalent rights, LeMaitre Vascular, LMAT, CFO, Joseph P. Pellegrino Jr.